Smart science to improve lives™
Croda Denmark

Denmark

Croda Denmark was formerly Brenntag Biosector (Biosector), acquired in 2019 and for more than 80 years has been dedicated to safe and effective adjuvants for use in human and veterinary vaccines. No other company can match our expertise in this area.

Our site at Frederikssund includes R&D, engineering, production QA/QC, administration, warehouse and distribution: 

  • World leading adjuvant specialist serving major human and veterinary vaccine producers
  • Industry leading R&D capabilities for a strong pipeline of innovative next generation vaccine adjuvants
  • Running the only aseptic and GMP certified manufacturing site for adjuvants globally

The combination of a passionate team, adjuvant expertise, industry-leading production facilities and a dedicated global sales network committed to understanding customer needs mean we can better serve our pharmaceutical customers through our classic portfolio and our rich development pipeline. We realise the vaccines and blood products of tomorrow require new and innovative adjuvants, so our R&D department is focused on the next generation of adjuvants.

Croda Denmark

Elsenbakken 23
3600 Frederikssund
Denmark
sustainable innovation plants in a lab

About us

We are the name behind high performance ingredients and technologies in some of the most successful brands in the world.

Croda Formulator at work in labs

Where we operate

Every day our global team, across 37 countries, work together to inspire our customers.

Further reading

Croda employees accepting award

Croda wins sustainability award at Syngenta Suppliers Awards

01 June 2022: Croda has been announced the winner of of the ‘reduction in carbon’ category at the Syngenta Suppliers Awards today, 1st June 2022. At the ceremony, held in Frankfurt, Germany, the...

Read more
Laboratory work

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.

Read more

Launch of Croda Pharma

23 May 2022: Our Health Care division becomes Croda Pharma

Read more

Croda celebrates Consumer Care wins

13 June 2022: Consumer Care wins the 'Innovation' award and the 'Creativity' award

Read more